<SEC-DOCUMENT>0000947871-23-000670-index.html : 20230612
<SEC-HEADER>0000947871-23-000670.hdr.sgml : 20230612
<ACCEPTANCE-DATETIME>20230612173233
ACCESSION NUMBER:		0000947871-23-000670
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230612
DATE AS OF CHANGE:		20230612

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keros Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001664710
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				811173868
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39264
		FILM NUMBER:		231009473

	BUSINESS ADDRESS:	
		STREET 1:		1050 WALTHAM STREET, SUITE 302
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
		BUSINESS PHONE:		617-314-6297

	MAIL ADDRESS:	
		STREET 1:		1050 WALTHAM STREET, SUITE 302
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORBIMED CAPITAL LLC
		CENTRAL INDEX KEY:			0001157524
		IRS NUMBER:				134133323
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		601 LEXINGTON AVENUE
		STREET 2:		54TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(212) 739-6400

	MAIL ADDRESS:	
		STREET 1:		601 LEXINGTON AVENUE
		STREET 2:		54TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>